Aktivieren Sie Javascript in Ihrem Browser, um unsere Webseite optimal zu nutzen.

Lipoprotein Lipase Antikörper (AA 300-327)

Name: Lipoprotein Lipase Antikörper (AA 300-327)
SKU: ABIN5531554
Price: 694.38 EUR
Availability: InStock

LPL Reaktivität: Human WB, FACS, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

Western Blot at 1:1000-1:2000 dilution Lane 1: MCF-7 whole cell lysate Lane 2: HL-60 whole cell lysate Lysates/proteins at 20 ug per lane. (Lipoprotein Lipase Antikörper (AA 300-327))

Overlay histogram showing Hela cells stained with Antibody (green line). (Lipoprotein Lipase Antikörper (AA 300-327))

Western blot analysis in HL-60 cell line lysates (35ug/lane). (Lipoprotein Lipase Antikörper (AA 300-327))

3 Abbildungen

Produktnummer ABIN5531554

Datenblatt (PDF)

Target Alle Lipoprotein Lipase (LPL) Antikörper anzeigen

Lipoprotein Lipase (LPL)
Bindungsspezifität
16

8

5

5

4

4

3

3

2

2

2

2

1

1

1

1
AA 300-327
Reaktivität
80

30

21

19

7

7

5

3

2

2

2

1

1

1

1

1
Human
Wirt
61

24

2
Kaninchen
Passende Sekundärantikörper
Klonalität
56

32
Polyklonal
Konjugat
39

8

7

3

2

2

2

2

2

2

2

2

2

1

1

1

1

1

1

1

1

1

1

1

1

1
Dieser Lipoprotein Lipase Antikörper ist unkonjugiert
Applikation
66

33

29

22

18

14

14

7

7

6

5

2

2

1

1

1

1
Western Blotting (WB), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))

Aufreinigung

This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogen

This LPL antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 300-327 amino acids from the Central region of human LPL.

Isotyp

Ig Fraction

Top Product

Discover our top product LPL Primärantikörper
anti-Lipoprotein Lipase (LPL) (AA 28-474) antibody
LPL Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Lipoprotein Lipase (LPL) (AA 300-327) antibody
LPL Reaktivität: Human WB, IHC, ELISA, FACS Wirt: Kaninchen Polyclonal unconjugated

anti-Lipoprotein Lipase (LPL) (AA 55-316) antibody
LPL Reaktivität: Human WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

anti-Lipoprotein Lipase (LPL) antibody
LPL Reaktivität: Human WB, ICC, IF, IHC (p) Wirt: Kaninchen Polyclonal unconjugated

anti-Lipoprotein Lipase (LPL) (AA 162-246) antibody
LPL Reaktivität: Human IHC, ELISA, IF Wirt: Kaninchen Polyclonal unconjugated

anti-Lipoprotein Lipase (LPL) antibody (HRP)
LPL Reaktivität: Human, Ratte, Rind (Kuh), Meerschweinchen, Huhn WB, ELISA, IP Wirt: Maus Monoclonal 5D2 HRP

anti-Lipoprotein Lipase (LPL) antibody
LPL Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 2C5 unconjugated

anti-Lipoprotein Lipase (LPL) (AA 1-475) antibody
LPL Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated

anti-Lipoprotein Lipase (LPL) antibody
LPL Reaktivität: Human, Ratte, Maus, Syrischer Goldhamster, Cat WB, ELISA, FACS, IF, InhA Wirt: Maus Monoclonal 5D2 unconjugated

anti-Lipoprotein Lipase (LPL) antibody
LPL Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated

Applikationshinweise

For FACS starting dilution is: 1:25

For WB starting dilution is: 1:1000

For IHC-P starting dilution is: 1:10~50

Beschränkungen

Nur für Forschungszwecke einsetzbar
Format

Liquid

Konzentration

0.5 mg/mL

Buffer

Supplied in PBS with 0.09 % (W/V) sodium azide.

Konservierungsmittel

Sodium azide

Vorsichtsmaßnahmen

This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung

4 °C,-20 °C

Informationen zur Lagerung

Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
Target

Lipoprotein Lipase (LPL)

Andere Bezeichnung

LPL (LPL Produkte)

Hintergrund

LPL encodes lipoprotein lipase, which is expressed in heart, muscle, and adipose tissue. LPL functions as a homodimer, and has the dual functions of triglyceride hydrolase and ligand/bridging factor for receptor-mediated lipoprotein uptake. Severe mutations that cause LPL deficiency result in type I hyperlipoproteinemia, while less extreme mutations in LPL are linked to many disorders of lipoprotein metabolism. [provided by RefSeq].

Molekulargewicht

53 kDa

Gen-ID

4023

UniProt

P06858

Pathways

Lipid Metabolism